Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In a new interview with Scientifica, Dr Adam Packer reveals plans for the 2019 Sculpted Light in the Brain conference, to be held at the Royal Society in June.

Dr Adam Packer is co-organising the third annual Sculpted Light in the Brain conference, to be held at the Royal Society on 20 - 21 June 2019.

Sculpted Light in the Brain is a recurring conference (founded in 2017) aimed at fostering collaborations between neuroscientists, computer scientists, optics researchers, and other scientists who share the common interest of using and developing novel technologies to observe and control neural activity in the awake, behaving brain. “Sculpted Light” refers to a broad class of methods where light is shaped to probe neural function.

The meeting aims to promote future collaboration opportunities by gathering established scientists and the next generation of researchers from these fields to discuss future technologies that will enable real time optical communication with the living brain.

In an interview with Scientifica released yesterday, Dr Packer discusses the conference, including which topics and techniques are covered and how to register to attend. The full interview can be viewed here.

 

Neuroscience has been revolutionised by the use of light to interrogate brain function. We have calcium imaging for monitoring the activity of neurons and parts of neurons, and we have optogenetics for manipulating neural activity. Sculpted light refers to the process of changing the shape of light to make it more useful for both imaging and photostimulation purposes, and that's the fundamental theme of this conference. With the advent of novel optical approaches, the conventional electrical recording and manipulation methods are being complimented and at times even replaced with these light-based approaches. But we still have a lot of work to do to reach the speed, specificity and range necessary to understand and control neural activity. And that's what we want to talk about: sculpted light in the brain to better understand brain function  - Dr Adam Packer

Dr Packer previously developed a new approach using two-photon imaging and optogenetics to both readout and manipulate neural circuit activity in vivo. His group here at DPAG uses all-optical interrogation techniques that he helped pioneer to investigate neural coding principles.

Dr Packer has more than 10 years of experience designing, building, and optimising two-photon microscopes to expand their capabilities, with specific expertise in optogenetics, calcium imaging, multi-cell targeted photostimulation, digital holography, and software development.

 

Similar stories

Mootaz Salman set to target new treatments for stroke

The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke.

New BBSRC grant to further our insights into how the cortex controls sleep

Professor of Sleep Physiology Vladyslav Vyazovskiy and Professor of Developmental Neuroscience Zoltán Molnár have been awarded a Project Grant from the Biotechnology and Biological Sciences Research Council (BBSRC) for “Brain mechanisms of sleep: top-down or bottom-up?”

Raised intracellular chloride levels underlie the effects of tiredness in cortex

A new study, co-authored by Professor Vladyslav Vyazovskiy, published in Nature Neuroscience, has revealed that intracellular chloride levels within cortical pyramidal neurons reflect sleep–wake history.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.